OpenAI and Ginkgo Bioworks demonstrated that generative AI integrated with an autonomous laboratory workflow can design, iterate and execute real biology experiments at scale, accelerating experimental cycles and discovery. The collaboration showed AI‑driven proposals validated in wet‑lab settings, shortening the design–test–learn loop for biological research and development. Autonomous labs link computational design to robotic execution; this combination aims to reduce manual bottlenecks in early R&D and enable faster optimization of molecules and pathways. The result is an industry signal that AI plus lab automation can materially accelerate preclinical work, with implications for discovery timelines and capital efficiency.